#$%^&*AU2018206777A120180809.pdf#####Abstract Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also 0 provided are methods of producing drypowder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.